Citation: Cj. Eagles et U. Martin, NONPHARMACOLOGICAL MODIFICATION OF CARDIAC RISK-FACTORS - PART 3 - SMOKING CESSATION AND ALCOHOL-CONSUMPTION, Journal of clinical pharmacy and therapeutics, 23(1), 1998, pp. 1-9
Citation: Cj. Eagles et Mj. Kendall, THE EFFECTS OF COMBINED TREATMENT WITH BETA(1)-SELECTIVE RECEPTOR ANTAGONISTS AND LIPID-LOWERING DRUGS ON FAT-METABOLISM AND MEASURES OF FATIGUE DURING MODERATE INTENSITY EXERCISE - A PLACEBO-CONTROLLED STUDY IN HEALTHY-SUBJECTS, British journal of clinical pharmacology, 43(3), 1997, pp. 291-300
Citation: Cj. Eagles et al., A COMPARISON OF THE EFFECTS OF FLUVASTATIN AND BEZAFIBRATE ON EXERCISE METABOLISM - A PLACEBO-CONTROLLED STUDY IN HEALTHY NORMOLIPIDEMIC SUBJECTS, British journal of clinical pharmacology, 41(5), 1996, pp. 381-387
Citation: Cj. Eagles et al., NONPHARMACOLOGICAL MODIFICATION OF CARDIAC RISK-FACTORS .1., Journal of clinical pharmacy and therapeutics, 21(5), 1996, pp. 289-296